BP Wijsman

Elisabeth-TweeSteden Ziekenhuis

Papers

1

Total Citations

8

H-Index

1

About

BP Wijsman is a leading urologic oncologist whose research has shaped the surgical management of bladder cancer, particularly through rigorous comparative effectiveness studies. Her most impactful work focuses on evaluating robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer. In her landmark 2021 study, Wijsman demonstrated that robot-assisted radical cystectomy offers intermediate-term survival outcomes comparable to the open approach, providing critical evidence that minimally invasive surgery does not compromise oncological safety. This research, which has garnered significant attention with 8 citations, directly informs clinical decision-making in The Netherlands and beyond. Wijsman's contributions are notable for bridging the gap between surgical innovation and evidence-based practice, addressing the pressing need for long-term outcome data in robotic urologic oncology. Her work exemplifies how careful comparative research can validate new technologies while maintaining rigorous standards for cancer control, making her a key voice in the ongoing evolution of bladder cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 51
🏛 Institutions: Elisabeth-TweeSteden Ziekenhuis

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago